April Portfolio Review: 8 Stocks You Should Buy Today (+ WIT, TWST News)
I share big news from our genomics play, Twist Bioscience (TWST), and our Indian tech consultant, Wipro Ltd. (NYSE: WIT). I advise to a new buy-up-to price for WIT.
Read MoreI share big news from our genomics play, Twist Bioscience (TWST), and our Indian tech consultant, Wipro Ltd. (NYSE: WIT). I advise to a new buy-up-to price for WIT.
Read MoreIn recent months, we’ve highlighted trends ranging from genomics (DNA technology) to competitive video gaming to gritty, old infrastructure construction.
Read MorePosted by paul kranowitz | Apr 14, 2021
This week, I wanted to make sure to address the elephant in the room: the news that federal health agencies called for a pause in use of the Johnson & Johnson COVID-19 vaccine.
Read MorePosted by paul kranowitz | Apr 7, 2021
Last week, a member of my team asked me: “Adam, have you explained to the Green Zone Fortunes readers how you use the Green Zone system in your options trading service?”
Read MorePosted by paul kranowitz | Mar 31, 2021
This week, I address a question from subscriber Keith, who wrote to us:
I’m new to investing, and this is probably a really dumb question, but I’ve seen and heard, where people talk about, ‘I made a 69% gain.’ Can you please explain to me how this percentage was calculated? What’s the numerator, what’s the denominator?
Read MoreIn his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below